Innovation is the cornerstone of AbbVie’s business as a global biopharmaceutical company. Their focus is on developing medicines that can provide strong clinical performance, measurable patient benefit and economic value, particularly in areas where there is significant need, such as hepatitis C, neuroscience, immunology, oncology, chronic kidney disease and women’s health.
AbbVie combines advanced science, global capabilities and passion to provide innovative therapies that help people manage some of the most serious health conditions.
member
With about 70 patents, series of fundings, and an innovative product line, primarily to address the prevention and removal of microbial biofilms, finally the 19-year-old company makes it big in the bioscience industry!
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.